CSGCX
Price
$42.93
Change
-$0.40 (-0.92%)
Updated
Jun 13 closing price
Net Assets
1.37B
RLBGX
Price
$35.65
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

CSGCX vs RLBGX

Header iconCSGCX vs RLBGX Comparison
Open Charts CSGCX vs RLBGXBanner chart's image
Calvert Balanced C
Price$42.93
Change-$0.40 (-0.92%)
VolumeN/A
Net Assets1.37B
American Funds American Balanced R6
Price$35.65
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
CSGCX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSGCX vs. RLBGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSGCX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 244B vs. CSGCX (1.38B). RLBGX pays higher dividends than CSGCX: RLBGX (2.23) vs CSGCX (0.67). CSGCX was incepted earlier than RLBGX: CSGCX (31 years) vs RLBGX (16 years). CSGCX (1.66) is less costly to investors than RLBGX (0.25). CSGCX is a more actively managed with annual turnover of: 153.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than CSGCX: RLBGX (250) vs CSGCX (1000). RLBGX annual gain was more profitable for investors over the last year : 5.63 vs. CSGCX (3.02). RLBGX return over 5 years is better than : 40.35 vs. CSGCX (33.77).
CSGCXRLBGXCSGCX / RLBGX
Total Expense Ratio1.660.25664%
Annual Report Gross Expense Ratio1.660.25664%
Fund Existence31 years16 years-
Gain YTD1.0754.59223%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B244B1%
Annual Yield % from dividends0.672.2330%
Returns for 1 year3.025.6354%
Returns for 3 years33.6933.78100%
Returns for 5 years33.7740.3584%
Returns for 10 years36.6760.8760%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.680.06
+3.70%
C4 Therapeutics
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp